Glazer Capital LLC’s Syneron Medical Ltd ELOS Stock Holding History

Glazer Capital LLC’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-207,300	Closed	-$2.27M	–	118
2017 Q2	$2.27M	Buy	+207,300	New	+$2.27M	0.14%	59

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Glazer Capital LLC's ELOS Position: Q3 2017 in Review

Glazer Capital LLC sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 207,300 shares — an estimated $2.27M sold.

Glazer Capital LLC first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $2.27M in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

Glazer Capital LLC reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
Glazer Capital LLC sold 207,300 Syneron Medical Ltd shares in Q3 2017, an estimated $2.27M.
Glazer Capital LLC first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
Glazer Capital LLC's Syneron Medical Ltd position peaked at $2.27M in Q2 2017.
4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Glazer Capital LLC's 13F filing for Q3 2017, filed 14 Nov 2017.